- Investing Ideas
- /
- Global Pharmaceuticals & Biotech Undervalued Stocks Based On Cash Flows
Global Pharmaceuticals & Biotech Undervalued Stocks Based On Cash Flows
Results
54
Companies with promising cash flow potential yet trading below their fair value, as determined by SWS DCF valuation, signaling opportunity for value-oriented investors.
54 companies
PharmaResearch
Market Cap: ₩5.4t
Operates as a biopharmaceutical company primarily in South Korea.
A214450
₩517,000.00
7D
4.8%
1Y
250.0%
Nanjing Vazyme Biotech
Market Cap: CN¥9.0b
Offers technology solutions for life science, biomedicine, and in vitro diagnostics.
688105
CN¥22.55
7D
-0.4%
1Y
19.4%
Renata
Market Cap: ৳55.9b
Manufactures, markets, and distributes human pharmaceuticals, animal health medicines, nutritionals, and vaccines in Bangladesh.
RENATA
৳487.50
7D
-0.2%
1Y
-35.1%
Niagen Bioscience
Market Cap: US$1.0b
Operates as a bioscience company engages in developing healthy aging products.
NAGE
US$12.71
7D
-11.8%
1Y
406.4%
Yuhan
Market Cap: ₩8.1t
Manufactures and sells prescription drugs, over-the-counter drugs, veterinary drugs, and household goods in South Korea and internationally.
A000100
₩107,600.00
7D
3.3%
1Y
23.1%
Beijing Aosaikang Pharmaceutical
Market Cap: CN¥16.7b
Beijing Aosaikang Pharmaceutical Co., Ltd.
002755
CN¥18.02
7D
12.8%
1Y
89.9%
Akeso
Market Cap: HK$101.4b
A biopharmaceutical company, engages in the research, development, manufacture, and commercialization of antibody drugs worldwide.
9926
HK$113.00
7D
22.9%
1Y
208.3%
Mesa Laboratories
Market Cap: US$564.1m
Develops, designs, manufactures, sells, and services life sciences tools and quality control products and services in North America, Europe, the Asia Pacific, and internationally.
MLAB
US$103.40
7D
9.7%
1Y
8.7%
Natera
Market Cap: US$22.1b
A diagnostics company, provides molecular testing services worldwide.
NTRA
US$161.76
7D
-4.3%
1Y
47.7%
Biotage
Market Cap: SEK 11.5b
Provides solutions and products in the areas of drug discovery and development, analytical testing, and water and environmental testing.
BIOT
SEK 143.40
7D
0.2%
1Y
-14.4%
Diaceutics
Market Cap: UK£98.5m
A diagnostic commercialization company, provides data, data analytics, and implementation services for pharma and biotech companies.
DXRX
UK£1.17
7D
-0.9%
1Y
-10.0%
Viva Biotech Holdings
Market Cap: HK$2.9b
An investment holding company, engages in the provision of structure-based drug discovery services to biotechnology and pharmaceutical customers worldwide.
1873
HK$1.38
7D
-10.4%
1Y
170.6%
Essex Bio-Technology
Market Cap: HK$2.6b
An investment holding company, develops, manufactures, and sells biologic drugs in China, Hong Kong, and internationally.
1061
HK$4.50
7D
2.0%
1Y
86.7%
Strides Pharma Science
Market Cap: ₹80.4b
Develops, manufactures, and sells pharmaceutical products in Africa, Australia, North America, Europe, Asia, India, and internationally.
STAR
₹872.15
7D
-3.1%
1Y
-6.4%
Recordati Industria Chimica e Farmaceutica
Market Cap: €11.2b
Researches, develops, produces, and sells pharmaceuticals in Italy, the United States, Spain, France, Germany, Russia, Ukraine, Turkey, Portugal, North Africa, and internationally.
REC
€54.05
7D
1.2%
1Y
10.1%
Bruker
Market Cap: US$6.4b
Develops, manufactures, and distributes scientific instruments, and analytical and diagnostic solutions in the United States, Europe, the Asia Pacific, and internationally.
BRKR
US$42.45
7D
3.0%
1Y
-31.8%
Genus
Market Cap: UK£1.4b
Operates as an animal genetics company in North America, Latin America, the United Kingdom, rest of Europe, the Middle East, Russia, Africa, and Asia.
GNS
UK£21.25
7D
3.9%
1Y
23.0%
Celltrion
Market Cap: ₩39.5t
A biopharmaceutical company, engages in the development, production, and sale of various therapeutic proteins for the treatment of oncology diseases.
A068270
₩178,800.00
7D
12.0%
1Y
6.5%